focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

25 Nov 2013 07:00

RNS Number : 7696T
China Growth Opportunities Ltd
25 November 2013
 



CHINA GROWTH OPPORTUNITIES LIMITED

 

UNAUDITED HALF-YEARLY RESULTS

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2013

 

 

KEY POINTS

 

· Net assets at 30 September 2013 of £0.1 million (31 March 2013: £0.2 million).

· Net assets per share at 30 September 2013 of 0.11p (31 March 2013: 0.29p).

 

Proposed post period end changes

· Proposed resignation of Rhys Davies as a Director and appointment of additional Directors to the Board.

· Proposed change of Company name to Scarborough Oriental Ventures Limited.

 

A copy of the half-yearly results will shortly be available for inspection on the Company's website: www.chinagrowthopportunities.com. Copies can be obtained in hard copy form free of charge, from the Company Secretary, Elysium Fund Management Limited, PO Box 650, 1st Floor, Royal Chambers, St Julian's Avenue, St Peter Port, Guernsey, GY1 3JX.

For further information please visit www.chinagrowthopportunities.com or contact:

 

Rhys Davies

Chairman

Tel: +41 79 620 0215

James Maxwell, Nick Donovan

N+1 Singer

Tel: +44 207 496 3000

Elysium Fund Management Limited

PO Box 650

1st Floor

Royal Chambers

St Peter Port

Guernsey

GY1 3JX

 

Tel: +44 1481 810 100

Fax: +44 1481 810 120

e-mail: elysium@elysiumfundman.com

 

 

CHAIRMAN'S STATEMENT

I am pleased to have the opportunity to present the unaudited half-yearly results of China Growth Opportunities Limited (the "Company") for the six-month period ended 30 September 2013.

 

Results

The net asset value of the Company at 30 September 2013 was £77,000 (30 September 2012: £333,000, 31 March 2013: £200,000), equal to 0.11p per Ordinary Share (30 September 2012: 0.48p per Ordinary Share, 31 March 2013: 0.29p per Ordinary Share). The 61.5% decrease in net asset value from 31 March 2013 was due to the net loss for the period of £123,000 (30 September 2012: loss of £169,000, 31 March 2013: loss of £302,000).

 

Share Price

The share price dropped during the period by 3% from the 31 March 2013 price of 0.775p to 0.750p per Ordinary Share at 30 September 2013 and, at the period end, the Ordinary Shares traded at a significant premium of 582% to the net asset value.

 

Proposed Post Period End Changes

The corporate and strategic changes mentioned in the last Annual Report and Financial Statements, have not yet occurred. However, it is still the intention for a number of changes to be carried out before this financial year end. To commence the next phase of development of the Company, it is envisaged that there will be a proposal to change the name of the Company to Scarborough Oriental Ventures Limited. This will provide the platform for a further fundraising programme to enable the Company to pursue an active investing strategy in its chosen markets.

 

In addition, there will be changes to the Board, with new Directors to be confirmed. As part of these changes, I expect to step down as a Director soon after the date of signing this report.

 

Investing Policy

The Company's objective is to provide shareholders with capital growth and income from investing in a portfolio of companies whose business operations are based in China. The Company will seek to invest as sole or lead investor in profitable, well-managed real estate and retail orientated businesses whose business operations are based in China.

 

Scarborough intends to utilise its resources and contacts in Hong Kong and China in order to generate deal flow and actively manage investments. Although there are no limits on the proportion of the Company's net assets which may be invested in any particular investment, the Directors will seek to ensure that the Company has a spread of investments. Investments are expected to be held for between approximately three to five years.

 

The Company will hold its investments through special purpose vehicles ("SPVs"). Borrowing may be undertaken at the SPV level and investments may initially be highly geared.

 

Investments

At 30 September 2013, the Company's only investment was an equity stake in Starlight Viewpoint Limited, which is part of Wan Wei and has been valued at nil (30 September 2012 and 31 March 2013: nil). It is highly unlikely that the Company will recover any value in Starlight Viewpoint Limited as Wan Wei has a history of bad debt problems and insufficient working capital to advance the business.

 

Outlook

As a Board we continue to adopt a cautious approach with our target fundraising and aim to make the proposed changes mentioned above in the coming weeks. We are hopeful that the Company will shortly be in a position to implement the investment strategy and start building a capital base with the intention of taking advantage of investment opportunities in China.

 

R Davies

14 November 2013

 

 

CONDENSED HALF-YEARLY STATEMENT OF COMPREHENSIVE INCOME

 

for the six months ended 30 September 2013

 

 

Note

1 April 2013 to

30 September 2013

1 April 2012 to

30 September 2012

1 April 2012 to

31 March 2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Investment gains and losses

Net unrealised change in fair value of investments

-

2,700

2,700

Loss from realisation of investments

-

(2,700)

(2,700)

------------

------------

------------

Total investment gains and losses

-

-

-

Income

Finance income

-

1

1

------------

------------

------------

Total income

-

1

1

Expenses

Administration fees

(50)

(50)

(100)

Directors' remuneration

(36)

(40)

(76)

Other expenses

(24)

(47)

(82)

Nominated adviser and broker's fees

(13)

(33)

(45)

------------

------------

------------

Total expenses

(123)

(170)

(303)

------------

------------

------------

Total comprehensive loss for the period/year

(123)

(169)

(302)

------------

------------

------------

Loss per share - basic and diluted

6

(0.18)p

(0.27)p

(0.45)p

 

 

 

CONDENSED STATEMENT OF FINANCIAL POSITION

as at 30 September 2013

Note

30 September 2013

30 September 2012

31 March 2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Non-current assets

Investments designated at fair value through profit or loss

-

-

-

----------

----------

----------

Current assets

Other receivables

5

5

7

Cash and cash equivalents

134

389

271

----------

----------

----------

139

394

278

----------

----------

----------

Total assets

139

394

278

----------

----------

----------

Current liabilities

Payables and accruals

(62)

(61)

(78)

----------

----------

----------

Net assets

77

333

200

----------

----------

----------

Capital and reserves attributable to equity

holders of the Company

Share capital

10

700

700

700

Other reserve

2,293

2,293

2,293

Distributable reserves

(2,916)

(2,660)

(2,793)

---------

---------

----------

Total equity shareholders' funds

77

333

200

----------

----------

----------

Net Asset Value per Ordinary Share - basic and diluted

9

0.11p

0.48p

0.29p

 

 

CONDENSED HALF-YEARLY STATEMENT OF CHANGES IN EQUITY

 

 

for the six months ended 30 September 2013 (unaudited)

 

 

Share capital

Other reserve

Distributable reserves

 

Total

 

£'000

£'000

£'000

£'000

 

Balance at 31 March 2013

700

2,293

(2,793)

200

 

Total comprehensive loss for the period

 

Loss for the period

-

-

(123)

(123)

 

Other comprehensive loss for the period

-

-

-

-

 

----------

----------

----------

----------

 

Balance at 30 September 2013

700

2,293

(2,916)

77

 

----------

----------

----------

----------

 

 

for the six months ended 30 September 2012 (unaudited)

 

 

Share capital

Other reserve

Distributable reserves

 

Total

 

£'000

£'000

£'000

£'000

 

Balance at 31 March 2012

500

2,293

(2,241)

552

 

Share Capital Issued (note 10)

200

-

-

200

 

Return of Capital (note 7)

-

-

(250)

(250)

 

Total comprehensive loss for the period

 

Loss for the period

-

-

(169)

(169)

 

Other comprehensive loss for the period

-

-

-

-

 

----------

----------

----------

----------

 

Balance at 30 September 2012

700

2,293

(2,660)

333

 

----------

----------

----------

----------

 

 

for the year ended 31 March 2013 (audited)

 

 

Share capital

Other reserve

Distributable reserves

 

Total

 

£'000

£'000

£'000

£'000

 

Balance at 31 March 2012

500

2,293

(2,241)

552

 

Issue of Ordinary Shares (note 10)

200

-

-

200

 

Return of capital (note 7)

-

-

(250)

(250)

 

Total comprehensive loss for the year

 

Loss for the year

-

-

(302)

(302)

 

Other comprehensive loss

-

-

-

-

 

----------

----------

----------

----------

 

Balance at 31 March 2013

700

2,293

(2,793)

200

 

----------

----------

----------

----------

 

 

 

CONDENSED HALF-YEARLY STATEMENT OF CASH FLOWS

for the six months ended 30 September 2013

 

 

1 April 2013 to

30 September 2013

1 April 2012 to

30 September 2012

1 April 2012 to

31 March 2013

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Cash flows from operating activities

Finance income received

-

1

1

Administration fees paid

(50)

(50)

(100)

Directors' remuneration paid

(36)

(42)

(78)

Other expenses paid

(38)

(58)

(78)

Nominated adviser and broker's fees paid

(13)

(33)

(45)

----------

----------

----------

Net cash outflow from operating activities

(137)

(182)

(300)

Cash flow from financing activities

Issue of Ordinary Shares

-

200

200

Return of capital

-

(250)

(250)

----------

----------

----------

Net cash outflow from financing activities

-

(50)

(50)

----------

----------

----------

----------

----------

----------

Decrease in cash and cash equivalents

(137)

(232)

(350)

----------

----------

----------

Cash and cash equivalents brought forward

271

621

621

Decrease in cash and cash equivalents

(137)

(232)

(350)

----------

----------

----------

Cash and cash equivalents carried forward

134

389

271

----------

----------

----------

 

 

NOTES TO THE UNAUDITED HALF-YEARLY RESULTS

for the six months ended 30 September 2013

1. General Information

The Company is an authorised closed-ended investment company domiciled and incorporated as a limited liability company in Guernsey.

 

The registered office of the Company is 1st Floor, Royal Chambers, St Julian's Avenue, St Peter Port, Guernsey, GY1 3JX.

 

The Company's objective is to provide shareholders with capital growth and income from investing in a portfolio of companies whose business operations are based in China. The Company will seek to invest as sole or lead investor in profitable, well-managed real estate and retail orientated businesses whose business operations are based in China.

 

The Investor intends to utilise its resources and contacts in Hong Kong and China in order to generate deal flow and actively manage investments. Although there are no limits on the proportion of the Company's net assets which may be invested in any particular investment, the Directors will seek to ensure that the Company has a spread of investments. Investments are expected to be held for between approximately three to five years.

 

The Company will hold its investments through special purpose vehicles ("SPVs"). Borrowing may be undertaken at the SPV level and investments may initially be highly geared."

 

The Company's investment activities are self-managed.

 

The Company's Ordinary Shares are traded on AIM, a market operated by the London Stock Exchange.

 

 

2. Statement of Compliance

These unaudited half-yearly results, which have not been independently reviewed or audited, have been prepared in accordance with International Accounting Standard 34: Interim Financial Reporting. They do not include all of the information required for full annual financial statements and should be read in conjunction with the audited financial statements for the year ended 31 March 2013.

 

The unaudited half-yearly results were approved by the Board of Directors on 14 November 2013.

 

 

3. Significant Accounting Policies

These unaudited half-yearly results have adopted the same accounting policies as the last audited financial statements, which were prepared in accordance with International Financial Reporting Standards ("IFRS"), issued by the International Accounting Standards Board, interpretations issued by the IFRS Interpretations Committee and applicable legal and regulatory requirements of Guernsey Law and reflect the accounting policies as disclosed in the Company's last audited financial statements, which have been adopted and applied consistently.

 

 

4. Critical Accounting Estimates and Judgements

The preparation of these unaudited half-yearly results requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expenses. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are outlined below:

 

Fair value of financial instruments

The Company may, from time to time, hold financial investments that are not quoted in active markets. Fair values of such investments are determined using valuation techniques. Where valuation techniques are used to determine fair values, they are validated and periodically reviewed by the Board of Directors.

Functional currency

The Board of Directors considers Sterling to be the currency that most faithfully represents the economic effect of the underlying transactions, events and conditions.

 

 

5. Segmental Information

In accordance with International Financial Reporting Standard 8: Operating Segments, it is mandatory for the Company to present and disclose segmental information based on the internal reports that are regularly reviewed by the Board in order to assess each segment's performance and to allocate resources to them.

 

Management information for the Company as a whole is provided internally to the Directors for decision-making purposes. The Directors' asset allocation decisions are based on a single, integrated investment strategy and the Company's performance is evaluated on an overall basis, being investment in a portfolio of companies whose business operations are focused in China.

 

The internal reporting provided to the Board for the Company's assets, liabilities and performance is prepared on a consistent basis with the measurement and recognition principles of IFRS.

 

There were no changes in the reportable segments during the period from 1 April 2013 to 30 September 2013.

 

There was no revenue generated by the Company during the period ((30 September 2012: bank interest of £1,000; 31 March 2013: bank interest of £1,000) arising from cash and cash equivalents, which was generated in Guernsey). The Company is domiciled in Guernsey.

 

 

6. Loss per Ordinary Share - basic and diluted

The loss per Ordinary Share is based on the loss for the period of £123,000 (30 September 2012: loss of £169,000;31 March 2013: loss of £302,000) and on a weighted average number of 70,000,709 Ordinary Shares in issue during the period (30 September 2012: 63,552,084 Ordinary Shares and 31 March 2013: 66,767,563 Ordinary Shares).

 

Following an Extraordinary General Meeting held on 28 May 2012, 44,999,992 Warrants were issued to qualifying shareholders on 29 May 2012. The average price, of the Ordinary Shares of 0.80 pence during the period was less than the exercise price of the Warrants (5.00 pence). Therefore, there was no dilution in the return per Ordinary Share.

 

 

7. Dividends and Return of Capital

The Directors do not propose an interim dividend for the period ended 30 September 2013 (30 September 2012 and31 March 2013: nil).

 

During the period ended 30 September 2013, the Board did not return any capital to shareholders of the Company (30 September 2012: £250,000, 31 March 2013: £250,000).

 

Any further returns of capital will be at the sole discretion of the Board and will be subject to the rate at which the Company's investments are realised and the Company's financial position at the time.

 

 

8. Tax effects of other comprehensive income

During the periods ended 30 September 2013, 30 September 2012 and 31 March 2013 there was no other comprehensive income disclosed in the statement of comprehensive income and, as a result, there were no tax effects arising thereon.

 

 

9. Net Asset Value per Ordinary Share

Basic

The basic net asset value per Ordinary Share is based on the net assets attributable to equity shareholders of £77,000(30 September 2012: £333,000; 31 March 2013: £200,000) and on 70,000,709 Ordinary Shares in issue at the end of the period (30 September 2012 and 31 March 2013: 70,000,709 Ordinary Shares).

 

Diluted

The 30 September 2013 mid-price of the Ordinary Shares of 0.75 pence (30 September 2012: 0.50 pence; 31 March 2013: 0.775 pence) was below the exercise price of the 44,999,992 Warrants (exercise price of 5.00 pence). Therefore, as at 30 September 2013, 30 September 2012 and 31 March 2013 the Subscription Warrants had no dilutive effect.

 

There were no other securities in issue at 30 September 2013, 30 September 2012 or 31 March 2013 which could or had a dilutive effect on the Company's Ordinary Shares.

 

10. Share Capital

30 September 2013

30 September 2012

31 March 2013

£'000

£'000

£'000

Authorised:

200,000,000 Ordinary Shares of 1p

2,000

2,000

2,000

----------

----------

----------

Allotted, called up and fully paid:

70,000,000 Ordinary Shares of 1p

700

500

500

----------

----------

----------

 

Following an Extraordinary General Meeting held on 28 May 2012, a resolution was passed by the shareholders enabling the Company to raise £200,000 (before expenses) through the issue of 20,000,000 Ordinary Shares to Scarborough at 1.0 pence per Ordinary Share, which represented a discount of 9.1% to the estimated net asset value per Existing Ordinary Share at 31 March 2012. The New Ordinary Shares represented 28.57% of the Company's enlarged issued Ordinary Share capital immediately following admission to trading on AIM on 29 May 2012. The New Ordinary Shares rank pari passu with the Ordinary Shares.

 

On 29 May 2012, the Company issued Subscription Warrants to Scarborough on the basis of one Subscription Warrant for each New Ordinary Share. Accordingly, following admission Scarborough held 20,000,000 Ordinary Shares and 20,000,000 Subscription Warrants.

 

On 29 May 2012, the Company issued 24,999,992 Bonus Issue Warrants to shareholders on the basis of one Bonus Issue Warrant for every two Existing Ordinary Shares. The terms of the Subscription Warrants and Bonus Issue Warrants are the same.

 

Each Warrant entitles the warrant-holder to subscribe for one Ordinary Share in cash at any time from 29 May 2012 to 29 May 2015 at a price of 5.0 pence per Ordinary Share. The Warrants have not been admitted to listing or trading on any stock exchange.

 

On 16 August 2012, the Company received notice to exercise 709 Warrants at an exercise price of 5.0 pence each. Following the Warrant exercise (and at the date of this report), 70,000,709 Ordinary Shares and 44,999,283 Warrants were in issue.

 

Pursuant to the authority renewed at the last Annual General Meeting, the Company has authority to utilise distributable reserves to buy back up to 14.99% of the Ordinary Shares in issue for cancellation. No shares were purchased for cancellation during the period (30 September 2012 and 31 March 2013: nil).

 

The Company is able to purchase up to 10% of the Ordinary Shares in issue and hold them as Treasury Shares.

 

 

11. Related Parties

Mr Davies holds 50% of Damille Partners II, which held 5,100,000 Ordinary Shares (7.29%) at30 September 2012 and the date of signing this report. In addition, Mr Davies holds 50% of Damille Partners Limited which held 8,651,920 Ordinary Shares (12.36%) at 30 September 2012 and the date of signing this report.

 

Mr McCabe holds 100% of Scarborough Holding Company Limited, which held 20,000,000 Ordinary Shares (28.57%) at 30 September 2013 and the date of signing this report.

 

The Directors consider that there is no immediate or ultimate controlling party.

 

 

12. Events after the financial reporting date

There were no material events after the financial reporting date that required disclosure as at 14 November 2013.

 

 

13. Capital management policy and procedures

The Company's capital management objectives are to ensure that the Company will be able to continue as a going concern in order to maximise total return for shareholders and to maintain an optimal capital structure to minimise the cost of capital.

 

The Company's borrowing policy, which is part of its new Investing Policy, is that borrowing may be undertaken at the SPV level and investments may initially be highly geared.

 

The Board monitors and reviews the structure of the Company's capital on an ad hoc basis. This review includes:

· The need to obtain funds for new investments, as and when they arise.

· The current and future levels of gearing.

· The need to buy back Ordinary Shares for cancellation or to be held in treasury, which takes account of the difference between the net asset value per Ordinary Share and the Ordinary Share price.

· The current and future dividend policy; and

· The current and future return of capital policy.

 

The Company is not subject to any externally imposed capital requirements.

 

-- ENDS --

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGGBAGUPWGCP
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.